Edition:
United Kingdom

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

0.58USD
18 Jul 2018
Change (% chg)

$0.01 (+1.40%)
Prev Close
$0.57
Open
$0.59
Day's High
$0.59
Day's Low
$0.56
Volume
54,538
Avg. Vol
78,737
52-wk High
$2.55
52-wk Low
$0.45

Latest Key Developments (Source: Significant Developments)

Arca Biopharma Q1 Loss Per Share $0.20
Tuesday, 8 May 2018 

May 8 (Reuters) - ARCA Biopharma Inc ::ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q1 LOSS PER SHARE $0.20.  Full Article

Arca Biopharma announces issuance of European patent on cardiovascular disease treatment methods
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Arca Biopharma Inc :Arca Biopharma announces issuance of European patent for treating cardiovascular diseases and conditions with a new chemical entity utilizing genetic targeting.Arca Biopharma- believes current cash, cash equivalents,marketable securities will be sufficient to fund its operations through end of Q2 of 2018​.  Full Article

ARCA Biopharma announces third quarter financial results
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Arca Biopharma Inc :ARCA Biopharma announces third quarter 2017 financial results and provides business update.Q3 loss per share $0.39.ARCA Biopharma Inc - anticipate reporting top-line data for Genetic-AF clinical trial​ late in Q1 of 2018.ARCA Biopharma Inc - ‍expects research and development expenses in 2017 to be higher than 2016​.  Full Article

Arca Biopharma posts Q2 loss per share $0.43
Tuesday, 9 Aug 2016 

Arca Biopharma Inc : Arca Biopharma announces second quarter 2016 financial results and provides business update .Q2 loss per share $0.43.  Full Article

BRIEF-Arca Biopharma Q1 Loss Per Share $0.20

* ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE